US Patent Issued to Prothena Biosciences, Hoffmann-La Roche on April 7 for "Dosing regimes for treatment of synucleinopathies" (American, Swiss Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,295, issued on April 7, was assigned to Prothena Biosciences Ltd. (Dublin) and Hoffmann-La Roche Inc. (Little Falls, N.Y.).

"Dosing regimes for treatment of synucleinopathies" was invented by Jay Soto (San Francisco), Daniel Keith Ness (San Mateo, Calif.), Martin Koller (Rancho Santa Fe, Calif.), Diane Mould (Fort Myers, Fla.), Frank Boess (Basel, Switzerland), Meret Martin-Facklam (Basel, Switzerland), Valerie Cosson (Basel, Switzerland), Hans Peter Grimm (Basel, Switzerland), Ronald Gieschke (Basel, Switzerland), Sara Belli (Basel, Switzerland) and Silke Weber (Basel, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provide...